OB/GYN opens first Maternal Fetal Medicine clinical trial at MCW

OB/GYN opens first Maternal Fetal Medicine clinical trial at MCW

Anna Palatnik, MD
Dr. Anna Palatnik and the Department of Obstetrics and Gynecology is excited to announce that we are now part of a multicenter NIH –funded randomized trial called “CHAP” (Chronic Hypertension in Pregnancy).

The primary aim of this study is to evaluate the benefits and potential risks of using medication to treat mild chronic hypertension in pregnancy. Chronic hypertension (high blood pressure) can cause serious and sometimes life-threatening complications for the pregnant woman and her baby, but no one really knows how best to manage the condition during pregnancy.

While treatment of mild chronic hypertension is standard for the general population, it is uncertain whether treating these mild elevations during pregnancy is beneficial. Because the effects of chronic hypertension start early in pregnancy, only women less than 23 weeks gestation will participate in the study.

The study will monitor both mothers and babies for complications throughout the pregnancy, up until 6 weeks after birth, and will determine which treatment resulted in better outcomes for both mothers and babies.

For more information on current treatment recommendations for chronic hypertension in pregnancy, please visit the American College of Obstetricians and Gynecologists website. To learn more about the CHAP study, please visit the Clinical Trials website.

We are excited for the opportunity to help improve care for patients with mild chronic hypertension across the country!